NEW YORK CITY (dpa-AFX) - Amarin Corp. plc (AMRN) has completed
randomization of patients in its phase III cardiovascular outcomes study to
determine whether Vascepa will reduce cardiovascular risk in statin treated
patients that still have...
BASEL (dpa-AFX) - Genmab A/S (GMXAY.PK, GNMSF.OB) said that its
collaboration partner Novartis will start Phase III studies of the subcutaneous
formulation of ofatumumab in relapsing multiple sclerosis or MS with enrolment
of patients expected to...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.